We know that lung cancer is still the most common cause of cancer in the United States. And although a diagnosis of inoperable lung cancer is serious, there are various options for treatment. Some of these treatments may slow or reverse disease progression. They may ease symptoms or even leng...
Strategies for improving the results are discussed.doi:10.1016/0360-3016(80)90109-1Norman M. BleehenElsevier Inc.International Journal of Radiation Oncology, Biology, PhysicsI . Bleehen NM. The treatment of inoperable lung cancer by radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys 1980...
And immunotherapy is a new, exciting advance in lung cancer. This is the way we get medications to turn on the patient's own immune system, and then let the immune system go and attack the cancer. And that approach has provided some very exciting results. For some patients, we will ...
READ ALSO:B.C. centre providing new hope for patients with hard-to-fight cancers READ ALSO:B.C. woman must seek treatment overseas for inoperable lung cancer
Treatment options depend on the type of lung cancerpresent and the stage of the tumor. Types of Lung Cancer Lung cancercomprises a group of different types of tumors. Lung cancers usually are divided into two main groups that account for about 95% of all cases. ...
focused and potent radiation beams provides targeted tumor control in nearly all patients, reduces treatment-related illness, and may ultimately improve survival for patients with inoperable non-small cell lung cancer, according to a study in the March 17 issue of JAMA, a theme issue on cancer.收...
Although the Radiation Therapy Oncology Group confirmed SBRT as an alternative treatment modality for inoperable early-stage lung cancer [9], there are concerns about the safety and efficacy of SBRT in patients 80 years and older. A multicenter study reported that grade 2 radiation pneumonitis (RP...
The discovery of the association between EGFR mutations and the efficacy of EGFR tyrosine-kinase inhibitors (TKIs) has revolutionized the treatment paradigm for patients with non-small-cell lung cancer (NSCLC). Currently, third-generation EGFR TKIs, which are often characterized by potent central nerv...
Lung Cancer Volume 10, Issues 1–2, October 1993, Pages 149Abstract Combined treatment modalitiesCombined chemotherapy and radiotherapy versus best supportive care in the treatment of inoperable non-small-cell lung cancer : Leung WT, Shiu WCT, Pang JCK, Lau J, Tao M, Leung SF et al. ...
Interest in biological therapy for cancer has surged due to its precise targeting of cancer cells and minimized impact on surrounding healthy tissues. This